Quantum Genomics announces the appointment of international experts as members of its Scientific Advisory Board

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces the three other members of its Scientific Advisory Board Committee headed by Professor Pierre Corvol who was appointed on July 8, 2014.

[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2014/10/QGC_PR_SCIENTIFIC-ADVISORY-BOARD_20141027_UK.pdf” target=”_blank” title=”Download the pdf” size=”small” color=”red”]